| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/28/2002 | US6395292 Water swellable, semipermeable material |
| 05/28/2002 | US6395278 Prostate specific fusion protein compositions |
| 05/28/2002 | US6395277 Method and compositions for the treatment of cerebral palsy |
| 05/28/2002 | US6395276 Killing malignant b cells by contacting with protein having ribonuclease activity linked to antibody against b cell surface marker; anticancer agents |
| 05/28/2002 | US6395273 Orally administering polyclonal antibodies against tumor necrosis factor to mammal to reduce symptoms |
| 05/28/2002 | US6395272 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 05/28/2002 | US6395270 Activated protein C formulations |
| 05/28/2002 | US6395268 Administering antagonist of mammalian chemokine to reduce allogeneic reaction from tissue transplant; immunosuppressants |
| 05/28/2002 | US6395267 Inhibiting signal transduction in tumor necrosis factor receptors by identifying molecule that binds to specific amino acid sequence of human receptor, then bringing molecule in contact with receptor |
| 05/28/2002 | US6394975 Method to apply compositions to a surface |
| 05/28/2002 | CA2248006C Activated linkers and methods for making and purifying the same |
| 05/28/2002 | CA2192675C Methods for treating motor deficits |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2107993C Disinfecting shampoo composition for animals |
| 05/28/2002 | CA2071651C A parenterally administrable drug having thrombolytic activity and containing protein c |
| 05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 05/28/2002 | CA1341363C Insulinotropic hormone |
| 05/28/2002 | CA1341362C Human manganese superoxide dismutase cdna, its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase |
| 05/23/2002 | WO2002040718A2 Method to identify genes associated with chronic myelogenous leukemia |
| 05/23/2002 | WO2002040715A2 Molecules for disease detection and treatment |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040678A1 Small acid-soluble spore protein and uses thereof |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040675A1 Novel human tumor necrosis factor mutant proteins and their preparing methods and uses |
| 05/23/2002 | WO2002040674A2 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/23/2002 | WO2002040673A2 Compositions and methods relating to lung specific genes and proteins |
| 05/23/2002 | WO2002040672A2 Compositions and methods relating to breast specific genes and proteins |
| 05/23/2002 | WO2002040670A2 A human g-protein coupled receptor, hgprbmy8, expressed hig hly in brain |
| 05/23/2002 | WO2002040668A2 Proteins and dna sequences underlying these proteins used for treating inflammations |
| 05/23/2002 | WO2002040667A1 Method of diagnosing and treating lesion of crystalline lens using human crygs gene and coding product thereof |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040658A2 Isomerases |
| 05/23/2002 | WO2002040657A2 47169 and 33935, novel glycosyl transferases and uses therefor |
| 05/23/2002 | WO2002040656A2 47476, 67210, 49875, 46842, 33201, 83378, 84233, 64708, 85041, and 84234, novel human guanine nucleotide dissociation stimulator, glycosyltransferase, dead type helicase, centaurin, dehydrogenase/reductase, and metal transporter family members and uses thereof |
| 05/23/2002 | WO2002040650A2 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 05/23/2002 | WO2002040637A2 Antisense modulation of pi3k p85 expression |
| 05/23/2002 | WO2002040635A2 HUMAN RNase H1 MUTANTS |
| 05/23/2002 | WO2002040543A1 Functional fragment of the lectine receptor |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040539A2 Gpcr-like protein and nucleic acids encoding same |
| 05/23/2002 | WO2002040538A2 Regulation of human nmda receptor |
| 05/23/2002 | WO2002040537A2 Analogues and derivatives of gastrin releasing peptide (grp) |
| 05/23/2002 | WO2002040536A2 Acylated antimicrobial peptides |
| 05/23/2002 | WO2002040531A1 Lapemis hardwicki short chain neurotoxin and gene encoding it |
| 05/23/2002 | WO2002040529A2 Diastereomeric peptides and pharmaceutical compositions comprising them |
| 05/23/2002 | WO2002040524A1 A NOVEL POLYPEPTIDE-HOMO aFGF CONJUGATED FACTOR 10.78 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040523A1 A NOVEL POLYPEPTIDE-HOMO GLUTARYL- CoA DEHYDROGENASE 15.51 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040522A1 A NOVEL POLYPEPTIDE-HOMO TRANSCRIPTION GROWTH REGULATORY FACTOR β ACTIVATION PROTEIN 14.08 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 05/23/2002 | WO2002040521A1 A novel polypeptide-homo dna-dependent rna polymerase ac40 subunit inhibitor 9.68 and polynucleotide encoding said polypeptide |
| 05/23/2002 | WO2002040520A1 A novel polypeptide, a human striatum enriched phosphatase 14.85 and the polynucleotide encoding the polypeptide |
| 05/23/2002 | WO2002040519A1 A NOVEL POLYPEPTIDE, A HUMAN β -1,4 GALACTOSYL TRANSFERASE 13.2 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040516A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof |
| 05/23/2002 | WO2002040512A2 Human beta-defensin-3 |
| 05/23/2002 | WO2002040508A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 05/23/2002 | WO2002040506A2 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | WO2002040500A2 Method of prognosis and diagnosis of congestive heart failure |
| 05/23/2002 | WO2002040498A2 Reduction of antioxidant enzyme levels in tumor cells using antisense oligonucleotides |
| 05/23/2002 | WO2002040063A1 Multipurpose packages for sterilised products or products to be sterilised |
| 05/23/2002 | WO2002040045A2 Microspheres of pancreatic enzymes with high stability |
| 05/23/2002 | WO2002040044A2 Chemoattractant recruitment of dendritic cells for enhancement of immunization |
| 05/23/2002 | WO2002040041A2 Orally ingestible preparation of mistletoe lectins and method |
| 05/23/2002 | WO2002040040A1 Camptothecin compounds with a sulfhydryl group |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040022A1 Treatment of sexual dysfunction using bombesin antagonist |
| 05/23/2002 | WO2002040016A2 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | WO2002040013A1 Composition for stimulating the immune defence and iron metabolism, containing propionyl l-carnitine and lactoferrin |
| 05/23/2002 | WO2002040008A2 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 05/23/2002 | WO2002040004A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | WO2002039996A2 Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists |
| 05/23/2002 | WO2002039995A2 Combination therapy for estrogen-dependent disorders |
| 05/23/2002 | WO2002039994A2 Methods for the treatment and prevention of urinary stone disease |
| 05/23/2002 | WO2002039985A1 Parenterally administrable microparticles |
| 05/23/2002 | WO2002039978A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/23/2002 | WO2002039948A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | WO2002039923A2 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002032451A8 Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 05/23/2002 | WO2002016562A3 22244 and 8701, novel human dehydrogenases and uses thereof |
| 05/23/2002 | WO2002006324A3 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 05/23/2002 | WO2002003970A3 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2002002596A3 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 05/23/2002 | WO2001094545A3 A tumor suppressor pathway in c. elegans |
| 05/23/2002 | WO2001093804A3 Hepatitis c virus conjugates |
| 05/23/2002 | WO2001092484A3 Adjuvant preparation for the induction of specific immunity |
| 05/23/2002 | WO2001090145A3 57805, a human cadherin family member and uses thereof |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001087346A3 Dendritic cells loaded with toxic substances |
| 05/23/2002 | WO2001087284A3 Aldosterone antagonist composition for release during aldosterone acrophase |
| 05/23/2002 | WO2001085961A3 Human caspase-12 |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001085792A8 Mu-1, member of the cytokine receptor family |
| 05/23/2002 | WO2001085768A3 G-protein coupled receptors and uses therefor |
| 05/23/2002 | WO2001085208A3 Molecular antigen arrays and vaccines |
| 05/23/2002 | WO2001083774A3 Novel mutated form of arginine deiminase |